论监督者定位下我国独立董事的民事责任  

On the Civil Liability of Independent Director in China under the Orientation of Supervisor

作　　者：范志勇 Fan Zhiyong

机构地区：[1]北京交通大学法学院 [2]中国人民大学破产法研究中心

出　　处：《法治社会》2023年第5期81-92,共12页Law-Based Society

摘　　要：康美药业案引发了独立董事承担民事责任的范围与程度的争议。证券集团诉讼中过重的责任超越了独立董事的承受能力,背离了民事责任的调整目标。合理认定我国独立董事的民事责任,须建立在明确独立董事以监督为中心的功能定位的基础上。在独立董事民事责任的归责中,应以勤勉义务为重心,综合衡量独立董事是否具备违法性要件,宽容认定其主观过错,避免独立董事与“看门人”民事责任的混淆。为确保将独立董事最终可能承担的民事责任框定在合理限度之内,有必要构建公司豁免责任与承诺补偿、商业保险机制与限额赔偿相互配合的独立董事民事责任的舒缓制度体系。The Kangmei Pharmaceutical case has caused a dispute about the scope and degree of civil liability borne by independent directors.The excessive liability in securities group litigation exceeds the bearing capacity of independent directors and deviates from the adjustment goal of civil liability.The reasonable determination of the civil liability of the independent director in China should be based on a clear definition of the function of the independent director centering on supervision.In the attribution of civil liability of independent directors,the duty of care should be taken as the focus to comprehensively measure whether the independent directors have illegality requirements,leniently identify their subjective faults,and avoid the confusion of civil liability of independent directors and gatekeepers.In order to ensure that the civil liability that may eventually be borne by independent directors is framed within a reasonable limit,it is necessary to construct a relief system of civil liability for independent directors,in which the company exempts liability and promises compensation,commercial insurance mechanism and limited compensation cooperate.

关 键 词：独立董事 民事责任 监督功能 勤勉义务 限额赔偿 

分 类 号：D922.291.91[政治法律—经济法学]